Left ventricular dysfunction assessed by cardiac time interval analysis among different geometric patterns in untreated hypertension

Circulation Journal

Volumn 76, Issue 6, 2012, Pages 1409-1414

  Takasaki, Kunitsugu ^a   Miyata, Masaaki ^a   Imamura, Masakazu ^a   Yuasa, Toshinori ^a   Kuwahara, Eiji ^a   Kubota, Kayoko ^a   Kono, Mihoko ^a   Ueya, Nami ^a   Horizoe, Yoshihisa ^a   Chaen, Hideto ^a   Mizukami, Naoko ^a   Kisanuki, Akira ^a   Hamasaki, Shuichi ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Echocardiography; Hypertension; Left ventricular function; Left ventricular hypertrophy

Indexed keywords

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART CONTRACTION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE EJECTION TIME; HUMAN; MAJOR CLINICAL STUDY; MALE; RELAXATION TIME; SINUS RHYTHM; SYSTOLIC BLOOD PRESSURE; TEI INDEX;

ANALYSIS OF VARIANCE; BLOOD PRESSURE; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; JAPAN; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; PREDICTIVE VALUE OF TESTS; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84861626503     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1369     Document Type: Article

References (21)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
2. Kono M, Kisanuki A, Takasaki K, Nakashiki K, Yuasa T, Kuwahara E, et al. Left ventricular systolic function is abnormal in diastolic heart failure: Re-assessment of systolic function using cardiac time interval analysis. J Cardiol 2009; 53: 437-446.
3. Yip G, Wang M, Zhang Y, Fung JW, Ho PY, Sanderson JE. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: Time for a redefinition. Heart 2002; 87:121-125.
4. Yu CM, Lin H, Yang H, Kong SL, Zhang Q, Lee SW. Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation 2002; 105: 1195-1201.
5. Aizawa Y, Sakata Y, Mano T, Takeda Y, Ohtani T, Tamaki S, et al. Transition from asymptomatic diastolic dysfunction to heart failure with preserved ejection fraction: Roles of systolic function and ventricular distensibility. Circ J 2011; 75: 596-602.
6. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-1558.
7. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
8. Cho KI, Kim SM, Shin MS, Kim EJ, Cho EJ, Seo HS, et al. Impact of gestational hypertension on left ventricular function and geometric pattern. Circ J 2011; 75: S1170-S1176.
9. Tabau JF, Szlachic J, Braun S, Massie BM. Impaired left ventricular function reverse in hypertensive patients with left ventricular hypertrophy. Hypertension 1989; 14: 1-8.
10. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al; Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al; Chamber Quantification Writing Group. Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, aBranch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
12. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995; 26: 135-136.
13. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, et al. New index of combined systolic and diastolic myocardial performance:A simple and reproducible measure of cardiac function-a study in normal and dilated cardiomyopathy. J Cardiol 1995; 26: 357-366.
14. Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB. Doppler index combining systolic and diastolic myocardial performance: Clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996; 28: 658-664.
15. Dujardin KS, Tei C, Yeo TC, Hodge DO, Rossi A, Seward JB. Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy. Am J Cardiol 1998; 82: 1071-1076.
16. Yeo TC, Dujardin KS, Tei C, Mahoney DW, McGoon MD, Seward JB. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary ulmonary hypertension. Am J Cardiol 1998; 81: 1157-1161.
17. Keser N, Yildiz S, Kurtoǧ N, Dindar I. Modified TEI Index: A Promising parameter in essential hypertension? Echocardiography 2005; 22: 296-304.
18. Gur M, Yilmaz R, Demirbag R, Yildiz A, Ozdogru I, Bas MM, et al. Relationship between myocardial performance index and aortic distensibility in patients with essential hypertension. Int J Clin Pract 2008; 62: 138-142.
19. Liljedahl S, Kahan T, Lind L, Arnlöv J. The effects of antihypertensive treatment on the Doppler-derived myocardial performance index in patients with hypertensive left ventricular hypertrophy: Results from the Swedish irbesartan in left ventricular hypertrophy investigation versus atenolol (SILVHIA). Echocardiography 2009; 26: 753-758.
20. Palmieri V, Okin PM, Bella JN, Wachtell K, Oikarinen L, Gerdts E, et al. Electrocardiographic strain pattern and left ventricular diastolicfunction in hypertensive patients with left ventricular hypertrophy: The LIFE study. J Hypertens 2006; 24: 2079-2084.
21. Kono M, Kisanuki A, Ueya N, Kubota K, Kuwahara E, Takasaki K, et al. Left ventricular global systolic dysfunction has a significant role in the development of diastolic heart failure in patients with systemic hypertension. Hypertens Res 2010; 33: 1167-1173.